Skip to content

Evaluation of the Systemic Microcirculation as a Surrogate for Coronary Microcirculation in Women With ANOCA

Evaluation of the Systemic Microcirculation as a Surrogate for Coronary Microcirculation in Women With ANOCA: Insights Into Pathophysiology and Diagnosis Using Noninvasive, Innovative Techniques (NOCAWT)

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07558018
Acronym
NOCAWT
Enrollment
60
Registered
2026-04-30
Start date
2026-08-01
Completion date
2029-12-01
Last updated
2026-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Angina, Microvascular

Keywords

microcirculation, Laser Speckle Contrast Imaging, Sublingual videomicroscopy

Brief summary

The primary objective of this project is to validate a multi-modal systemic microvascular phenotyping platform-combining Laser Speckle Contrast Imaging (LSCI) and Sublingual Handheld Videomicroscopy (IDF imaging)-as a non-invasive surrogate for coronary microvascular function in women with ANOCA (Angina with Non-Obstructive Coronary Arteries). We aim to demonstrate that systemic microvascular signatures (microvascular reactivity and density) can predict coronary endotypes with high accuracy, potentially reducing the need for invasive diagnostics.

Detailed description

The study will involve women aged 18 to 65 years, with stable anginal chest pain and no coronary artery disease (ANOCA) (absence of coronary plaque in coronary angiography or computed tomography coronary angiography - CCTA), recruited at the National Institute of Cardiology (INC). The upper age limit was established to limit the influence of vascular senescence on the results.

Interventions

PROCEDUREInvestigation of Systemic Endothelial Microvascular Function

Investigation of Systemic Endothelial Microvascular Function

Sponsors

National Institute of Cardiology, Laranjeiras, Brazil
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years

Inclusion criteria

* Age 18-65 years * Anginal chest pain

Exclusion criteria

* Malignant neoplasms * Autoimmune diseases * Acute systemic diseases * Pregnancy or lactation * Iodine allergy * CAD on invasive coronary angiography or coronary computed tomography angiography (CCTA)

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of endothelium-dependent skin microvascular reactivity.Microvascular reactivity will be evaluated 20-minute rest in the supine position in a temperature-controlled room.Evaluation of systemic microvascular reactivity induced by endothelium-dependent agent (acetylcholine). Microvascular reactivity will be evaluated using a non-invasive and operator -independent methodology, named laser speckle contrast imaging, coupled with skin iontophoresis of vasodilator agents. Cutaneous microvascular flow will be measured in arbitrary perfusion units, divided by mean arterial pressure, to yield cutaneous vascular conductance.

Secondary

MeasureTime frameDescription
Evaluation of endothelium-independent skin microvascular reactivity.Microvascular reactivity will be evaluated 20-minute rest in the supine position in a temperature-controlled room.Evaluation of systemic microvascular reactivity induced by endothelium-independent agent (sodium nitroprusside). Microvascular reactivity will be evaluated using a non-invasive and operator -independent methodology, named laser speckle contrast imaging, coupled with skin iontophoresis of vasodilator agents. Cutaneous microvascular flow will be measured in arbitrary perfusion units, divided by mean arterial pressure, to yield cutaneous vascular conductance.
Evaluation of endothelium-dependent skin microvascular reactivity.Microvascular reactivity will be evaluated 20-minute rest in the supine position in a temperature-controlled room.Evaluation of systemic microvascular reactivity induced by postocclusive reactive hyperemia. Microvascular reactivity will be evaluated using a non-invasive and operator -independent methodology, named laser speckle contrast imaging. Cutaneous microvascular flow will be measured in arbitrary perfusion units, divided by mean arterial pressure, to yield cutaneous vascular conductance.
Evaluation of sublingual microcirculation.Microvascular reactivity will be evaluated 20-minute rest in the supine position in a temperature-controlled room.Sublingual microcirculatory density and perfusion will be assessed using a handheld camera based on incident dark-field (IDF) imaging.

Contacts

CONTACTEduardo Tibirica, MD, PhD
etibi@uol.com.br+55-21-99914-6075

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 6, 2026